BioCentury | Jan 23, 2021
Management Tracks

Yale’s Fuchs joins Genentech, Roche; plus Lineage’s Roberts jumps on Longboard as CFO and Avidity, Xalud, AVM, Novavax

...Separately, AVM also named Gary Grohmann, also a board member, as chief regulatory officer.Vaccines play Novavax Inc....
BioCentury | Jan 22, 2021
Product Development

Slaoui on Warp Speed’s successes, limitations and lessons

...five companies: AstraZeneca plc (LSE:AZN; NASDAQ:AZN), the Janssen Pharmaceuticals unit of Johnson & Johnson (NYSE:JNJ), Moderna Inc. (NASDAQ:MRNA), Novavax Inc....
...to the scaling-up of the manufacturing processes, hand-in-hand with the technical teams from companies like Novavax...
BioCentury | Jan 16, 2021
Management Tracks

FDA’s Schiller joins Aetion; plus Novavax, NHC, NextCure, Ziopharm, ONK

...where he helped advance legislation including the 21st Century Cures Act and FDA user fee reauthorizations.Novavax Inc....
...succeeds founder Anthony Killarney, who remains on the board of the Irish cell therapy company. BC Staff Novavax Aetion FDA Ziopharm ONK...
BioCentury | Jan 12, 2021
Product Development

Slaoui updates on COVID-19 vaccines, warns about slow enrollment in adolescent trial

...the Oxford/AstraZeneca vaccine could receive Emergency Use Authorization in late March, and a vaccine from Novavax...
...Authorization could come “somewhere towards the latter part of the month of March” he said. Novavax Inc....
...age 12 to 18 decide to participate” in the trial, he said. Steve Usdin Moderna Inc. Johnson & Johnson Novavax Inc. AstraZeneca...
BioCentury | Dec 31, 2020
Politics, Policy & Law

Innovations forged in the COVID crucible will reshape medicine

...biotechs a year ago have soared. For example, Novavax Inc....
BioCentury | Dec 29, 2020
Product Development

Inovio COVID vaccine leans toward T cell responses: Data Byte

...C, according to the company.Another candidate that is stable at 2-8° C is NVX-CoV2373 from Novavax Inc....
...planned to occur when 50% and 75% of 144 events have accrued. A representative for Novavax...
...epidemiology.Novavax, whose vaccine’s timeline is behind that of several others, lost $12.49 (10%) to $116.85 Monday. Sandi Wong NVX-CoV2373 INO-4800 Novavax Inc. Inovio...
BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...at the Parker Institute for Cancer Immunotherapy and was previously CSO at Tessa Therapeutics. Vaccine developer Novavax Inc....
BioCentury | Dec 19, 2020
Product Development

Dec. 18 COVID Quick Takes: COVAX tops up as Mesoblast falls on Phase III data; plus Novavax, Pfizer-BioNTech, J&J and COVAX

...exclusive rights to develop, manufacture and commercialize the bone marrow-derived mesenchymal stromal cell therapy for indications outside graft-versus-host disease.Novavax...
...ZealandThe European Commission concluded on Thursday exploratory talks to procure 100 million doses of NVX-CoV2373 from Novavax Inc....
...vaccine product from multiple vials should not be pooled. BC Staff PF-07302048 (BNT162, BNT162b2) NVX-CoV2373 Ad26.COV2.S (JNJ-78436735) Ryoncil (remestemcel-L) Pfizer Inc. BioNTech SE Novavax Inc. Johnson...
BioCentury | Dec 15, 2020
Product Development

Vaccines march forward & CAR Ts move earlier: a BioCentury podcast

...speed and efficacy that mRNA has. The other one to mention I think is the Novavax...
BioCentury | Dec 12, 2020
Product Development

RNA vaccines still outshine other modalities as two protein-based COVID-19 vaccines yield mixed results

...early results from two of the modality’s front-runners. Novavax Inc....
...of participants. The findings bode well for Novavax’s...
...Compound #), Insulin lispro Sanofi (Other), Admelog (Other) Novavax Johnson...
Items per page:
1 - 10 of 503
BioCentury | Jan 23, 2021
Management Tracks

Yale’s Fuchs joins Genentech, Roche; plus Lineage’s Roberts jumps on Longboard as CFO and Avidity, Xalud, AVM, Novavax

...Separately, AVM also named Gary Grohmann, also a board member, as chief regulatory officer.Vaccines play Novavax Inc....
BioCentury | Jan 22, 2021
Product Development

Slaoui on Warp Speed’s successes, limitations and lessons

...five companies: AstraZeneca plc (LSE:AZN; NASDAQ:AZN), the Janssen Pharmaceuticals unit of Johnson & Johnson (NYSE:JNJ), Moderna Inc. (NASDAQ:MRNA), Novavax Inc....
...to the scaling-up of the manufacturing processes, hand-in-hand with the technical teams from companies like Novavax...
BioCentury | Jan 16, 2021
Management Tracks

FDA’s Schiller joins Aetion; plus Novavax, NHC, NextCure, Ziopharm, ONK

...where he helped advance legislation including the 21st Century Cures Act and FDA user fee reauthorizations.Novavax Inc....
...succeeds founder Anthony Killarney, who remains on the board of the Irish cell therapy company. BC Staff Novavax Aetion FDA Ziopharm ONK...
BioCentury | Jan 12, 2021
Product Development

Slaoui updates on COVID-19 vaccines, warns about slow enrollment in adolescent trial

...the Oxford/AstraZeneca vaccine could receive Emergency Use Authorization in late March, and a vaccine from Novavax...
...Authorization could come “somewhere towards the latter part of the month of March” he said. Novavax Inc....
...age 12 to 18 decide to participate” in the trial, he said. Steve Usdin Moderna Inc. Johnson & Johnson Novavax Inc. AstraZeneca...
BioCentury | Dec 31, 2020
Politics, Policy & Law

Innovations forged in the COVID crucible will reshape medicine

...biotechs a year ago have soared. For example, Novavax Inc....
BioCentury | Dec 29, 2020
Product Development

Inovio COVID vaccine leans toward T cell responses: Data Byte

...C, according to the company.Another candidate that is stable at 2-8° C is NVX-CoV2373 from Novavax Inc....
...planned to occur when 50% and 75% of 144 events have accrued. A representative for Novavax...
...epidemiology.Novavax, whose vaccine’s timeline is behind that of several others, lost $12.49 (10%) to $116.85 Monday. Sandi Wong NVX-CoV2373 INO-4800 Novavax Inc. Inovio...
BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...at the Parker Institute for Cancer Immunotherapy and was previously CSO at Tessa Therapeutics. Vaccine developer Novavax Inc....
BioCentury | Dec 19, 2020
Product Development

Dec. 18 COVID Quick Takes: COVAX tops up as Mesoblast falls on Phase III data; plus Novavax, Pfizer-BioNTech, J&J and COVAX

...exclusive rights to develop, manufacture and commercialize the bone marrow-derived mesenchymal stromal cell therapy for indications outside graft-versus-host disease.Novavax...
...ZealandThe European Commission concluded on Thursday exploratory talks to procure 100 million doses of NVX-CoV2373 from Novavax Inc....
...vaccine product from multiple vials should not be pooled. BC Staff PF-07302048 (BNT162, BNT162b2) NVX-CoV2373 Ad26.COV2.S (JNJ-78436735) Ryoncil (remestemcel-L) Pfizer Inc. BioNTech SE Novavax Inc. Johnson...
BioCentury | Dec 15, 2020
Product Development

Vaccines march forward & CAR Ts move earlier: a BioCentury podcast

...speed and efficacy that mRNA has. The other one to mention I think is the Novavax...
BioCentury | Dec 12, 2020
Product Development

RNA vaccines still outshine other modalities as two protein-based COVID-19 vaccines yield mixed results

...early results from two of the modality’s front-runners. Novavax Inc....
...of participants. The findings bode well for Novavax’s...
...Compound #), Insulin lispro Sanofi (Other), Admelog (Other) Novavax Johnson...
Items per page:
1 - 10 of 503